Nova Eye Medical Limited (EYE.AX)
AUD 0.16
(0.0%)
AUD 0.16
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 23.32 Million | 17.02 Million | 13.37 Million | 13.39 Million | 12.76 Million | 16.14 Million |
| Cost of Revenue | 3.13 Million | 16.18 Million | 14.14 Million | 11.62 Million | 14.4 Million | 2.97 Million |
| Gross Profit | 20.19 Million | 842 Thousand | -765 Thousand | 1.76 Million | -1.63 Million | 13.16 Million |
| Operating Expenses | 23.99 Million | 12.69 Million | 9.11 Million | 6.73 Million | 5.53 Million | 21.29 Million |
| Selling, General and Administrative Expenses | 23.42 Million | 12.83 Million | 9.18 Million | 6.93 Million | 5.53 Million | 18.47 Million |
| Research and Development Expenses | - | 617 Thousand | 276 Thousand | 162 Thousand | 107 Thousand | 2.02 Million |
| Other Expenses | 567 Thousand | 145 Thousand | 72 Thousand | 201 Thousand | -63 Thousand | 1.68 Million |
| Cost and Expenses | 27.12 Million | 28.87 Million | 23.25 Million | 18.35 Million | 19.94 Million | 24.26 Million |
| Operating Income | -3.79 Million | -11.84 Million | -9.88 Million | -4.96 Million | -7.17 Million | -7.04 Million |
| Interest Expense | 70 Thousand | 54 Thousand | 64 Thousand | 68 Thousand | 63 Thousand | 1000.00 |
| Income Tax Expense | - | -1.7 Million | -321 Thousand | -894 Thousand | 3.07 Million | 1.3 Million |
| Earnings before Tax | -8.79 Million | -17 Million | -7.81 Million | -5.25 Million | -7.24 Million | -7.96 Million |
| Net Income | -8.79 Million | -15.29 Million | -7.49 Million | -4.35 Million | -6.99 Million | -6.66 Million |
| Earnings Per Share Basic | -0.04 | -0.10 | -0.05 | -0.03 | -0.05 | -0.05 |
| Earnings Per Share Diluted | -0.04 | -0.10 | -0.05 | -0.03 | -0.05 | -0.05 |
| Weighted Average Shares Outstanding | 204.14 Million | 160.16 Million | 148.53 Million | 147.51 Million | 147.47 Million | 147.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 204.14 Million | 160.16 Million | 148.53 Million | 147.51 Million | 147.47 Million | 147.47 Million |
| Gross Margin | 0.87 | 0.05 | -0.06 | 0.13 | -0.13 | 0.82 |
| EBIT Margin | -0.26 | -0.56 | -0.60 | -0.26 | -0.45 | -0.37 |
| Profit Margin | -0.38 | -0.90 | -0.56 | -0.33 | -0.55 | -0.41 |
| EBITDA | -5.97 Million | -9.48 Million | -7.88 Million | -3.66 Million | -5.74 Million | -6.01 Million |
| Earnings Before Tax Margin | -0.16 | -0.70 | -0.74 | -0.37 | -0.56 | -0.44 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 23.32 Million | 13.18 Million | 10.13 Million | 17.02 Million | 8.63 Million | 8.39 Million |
| Cost of Revenue | 17.9 Million | 1.92 Million | 8.81 Million | 16.18 Million | 7.2 Million | 8.97 Million |
| Gross Profit | 5.42 Million | 11.26 Million | 1.32 Million | 842 Thousand | 1.42 Million | -586 Thousand |
| Operating Expenses | 14.39 Million | 12.04 Million | 6.92 Million | 12.69 Million | 6.05 Million | 6.41 Million |
| Selling, General and Administrative Expenses | - | 11.47 Million | 6.92 Million | - | 4.08 Million | 6.65 Million |
| Research and Development Expenses | - | 567 Thousand | - | - | 617 Thousand | - |
| Other Expenses | - | -3 Million | - | 145 Thousand | -1.96 Million | 233 Thousand |
| Cost and Expenses | 32.29 Million | 13.97 Million | 15.74 Million | 28.87 Million | 13.26 Million | 15.39 Million |
| Operating Income | -8.96 Million | -786 Thousand | -5.6 Million | -11.84 Million | -4.63 Million | -7 Million |
| Interest Expense | 70 Thousand | 58 Thousand | 12 Thousand | 54 Thousand | 25 Thousand | 29 Thousand |
| Income Tax Expense | - | -2.57 Million | - | -1.7 Million | -1.28 Million | -429 Thousand |
| Earnings before Tax | -8.79 Million | -3.16 Million | -5.62 Million | -17 Million | -9.96 Million | -7.03 Million |
| Net Income | -8.79 Million | -3.16 Million | -5.62 Million | -15.29 Million | -8.68 Million | -6.6 Million |
| Earnings Per Share Basic | - | -0.01 | -0.03 | - | -0.05 | -0.04 |
| Earnings Per Share Diluted | - | -0.01 | -0.03 | - | -0.05 | -0.04 |
| Weighted Average Shares Outstanding | 204.14 Million | 217.03 Million | 195.77 Million | 160.16 Million | 169.12 Million | 149.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 204.14 Million | 217.6 Million | 195.77 Million | 160.16 Million | 169.12 Million | 149.73 Million |
| Gross Margin | 0.23 | 0.85 | 0.13 | 0.05 | 0.17 | -0.07 |
| EBIT Margin | - | -0.14 | -0.41 | - | -0.40 | -0.70 |
| Profit Margin | -0.38 | -0.24 | -0.55 | -0.90 | -1.01 | -0.79 |
| EBITDA | - | -1.79 Million | -4.18 Million | - | -3.44 Million | -5.89 Million |
| Earnings Before Tax Margin | -0.38 | -0.06 | -0.55 | -0.70 | -0.54 | -0.83 |
ARIES
SUNS
CPMV
3501
3522
SKA-B